A Phase 2 Study of EIK1001 in Combination with Pembrolizumab and Chemotherapy in Patients with Stage 4 Non-Small Cell Lung Cancer
Protocol No. | CTO-EIK1001-005 | Scope | National |
---|---|---|---|
Principal Investigator | Rohan Maniar | Treatment Type | Treatment |
Age Group | Adult | Phase | Phase II |